Total Payments
$1,247
2024 Payments
$407.24
Companies
12
Transactions
29
Medicare Patients
3,839
Medicare Billing
$217,557
Payment Breakdown by Category
Food & Beverage$1,247 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,247 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $486.14 | 7 | $0 (2024) |
| ABBVIE INC. | $145.68 | 3 | $0 (2024) |
| Lilly USA, LLC | $139.07 | 2 | $0 (2024) |
| Novo Nordisk Inc | $131.01 | 7 | $0 (2024) |
| Amgen Inc. | $114.17 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $72.19 | 1 | $0 (2021) |
| Astellas Pharma US Inc | $49.70 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $35.09 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.81 | 1 | $0 (2023) |
| Abbott Laboratories | $16.63 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $407.24 | 12 | Lilly USA, LLC ($139.07) |
| 2023 | $333.45 | 11 | Amgen Inc. ($114.17) |
| 2022 | $184.36 | 3 | AstraZeneca Pharmaceuticals LP ($132.80) |
| 2021 | $321.52 | 3 | AstraZeneca Pharmaceuticals LP ($249.33) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.88 | General |
| 08/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $75.37 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.06 | General |
| 06/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Biological | ||||||
| 05/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Respiratory | ||||||
| 04/04/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Diabetes | ||||||
| 03/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $121.81 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Diabetes | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: Respiratory | ||||||
| 01/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: Biological | ||||||
| 12/13/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.05 | General |
| 11/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: DIABETES | ||||||
| 10/11/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: VACCINES | ||||||
| 09/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.82 | General |
| 09/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Gastroenterology | ||||||
| 08/02/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.98 | General |
| 05/11/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Diabetes Care | ||||||
| 02/22/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $59.26 | General |
| Category: Respiratory | ||||||
| 02/08/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $114.17 | General |
| Category: Cardiology | ||||||
| 04/19/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $51.56 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $67.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,317 | 1,939 | $255,469 | $62,815 |
| 2022 | 20 | 1,055 | 1,371 | $236,261 | $56,687 |
| 2021 | 8 | 618 | 821 | $135,421 | $47,077 |
| 2020 | 10 | 849 | 1,044 | $175,905 | $50,979 |
Total Patients
3,839
Total Services
5,175
Medicare Billing
$217,557
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 254 | 426 | $94,572 | $19,615 | 20.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 179 | 179 | $41,528 | $10,574 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 150 | 190 | $28,690 | $8,347 | 29.1% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 48 | 95 | $25,175 | $4,692 | 18.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 59 | 59 | $9,735 | $4,172 | 42.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 193 | 193 | $7,334 | $2,826 | 38.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 83 | 83 | $5,810 | $2,352 | 40.5% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 21 | 31 | $11,439 | $1,976 | 17.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 16 | $7,648 | $1,515 | 19.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 83 | 135 | $4,185 | $1,268 | 30.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 26 | 49 | $5,586 | $1,130 | 20.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 23 | 23 | $1,058 | $796.26 | 75.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,453 | $792.55 | 32.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 21 | 22 | $3,300 | $731.70 | 22.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 37 | 97 | $3,007 | $660.53 | 22.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 15 | 30 | $1,140 | $486.60 | 42.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 23 | 23 | $1,150 | $459.90 | 40.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $517.00 | $178.20 | 34.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 20 | 21 | $147.00 | $144.06 | 98.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 96 | $768.00 | $59.97 | 7.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 13 | $91.00 | $28.60 | 31.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 15 | 136 | $136.00 | $10.12 | 7.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 259 | 396 | $87,912 | $18,415 | 20.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 221 | 258 | $38,958 | $12,259 | 31.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 102 | 102 | $23,664 | $4,842 | 20.5% |
About Gina Anderson, ARNP
Gina Anderson, ARNP is a Nurse Practitioner healthcare provider based in Bartlesville, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215952742.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gina Anderson, ARNP has received a total of $1,247 in payments from pharmaceutical and medical device companies, with $407.24 received in 2024. These payments were reported across 29 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,247).
As a Medicare-enrolled provider, Anderson has provided services to 3,839 Medicare beneficiaries, totaling 5,175 services with total Medicare billing of $217,557. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family, Family
- Location Bartlesville, OK
- Active Since 07/13/2006
- Last Updated 01/13/2020
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1215952742
Products in Payments
- BREZTRI (Drug) $249.89
- FARXIGA (Drug) $191.50
- MOUNJARO (Drug) $139.07
- Repatha (Biological) $114.17
- QULIPTA (Drug) $75.37
- XARELTO (Drug) $72.19
- UBRELVY (Drug) $70.31
- Veozah (Drug) $49.70
- AIRSUPRA (Drug) $44.75
- TRELEGY ELLIPTA (Drug) $35.09
- JARDIANCE (Drug) $29.81
- Ozempic (Drug) $19.44
- FREESTYLE LIBRE 3 (Device) $16.63
- Rybelsus (Drug) $15.78
- PREVNAR 20 (Biological) $14.17
- XIFAXAN (Drug) $12.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Bartlesville
Kori Sauer, Aprn, APRN
Nurse Practitioner — Payments: $4,330
Nurse Practitioner $4,330
Allison Littleford
Nurse Practitioner — Payments: $2,426
Nurse Practitioner $2,426
Kirsten White, Arnp, ARNP
Nurse Practitioner — Payments: $889.52
Nurse Practitioner $889.52
Nedra Edwards, Aprn, APRN
Nurse Practitioner — Payments: $742.46
Nurse Practitioner $742.46
Angela Finney, Np, NP
Nurse Practitioner — Payments: $516.85
Nurse Practitioner $516.85
Lisa Johnson
Nurse Practitioner — Payments: $485.88
Nurse Practitioner $485.88